These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 24802129)
21. Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels. Tremmel R; Herrmann K; Engst W; Meinl W; Klein K; Glatt H; Zanger UM Arch Toxicol; 2017 Oct; 91(10):3329-3339. PubMed ID: 28326452 [TBL] [Abstract][Full Text] [Related]
22. Highly selective bioactivation of 1- and 2-hydroxy-3-methylcholanthrene to mutagens by individual human and other mammalian sulphotransferases expressed in Salmonella typhimurium. Meinl W; Tsoi C; Swedmark S; Tibbs ZE; Falany CN; Glatt H Mutagenesis; 2013 Sep; 28(5):609-19. PubMed ID: 23894158 [TBL] [Abstract][Full Text] [Related]
23. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Meinl W; Pabel U; Osterloh-Quiroz M; Hengstler JG; Glatt H Int J Cancer; 2006 Mar; 118(5):1090-7. PubMed ID: 16161050 [TBL] [Abstract][Full Text] [Related]
24. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of human sulfotransferases in the bioactivation of nitro- and aminotoluenes. Glatt H; Sabbioni G; Monien BH; Meinl W Environ Mol Mutagen; 2016 May; 57(4):299-311. PubMed ID: 26924705 [TBL] [Abstract][Full Text] [Related]
25. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
26. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes. Glatt H; Pabel U; Meinl W; Frederiksen H; Frandsen H; Muckel E Carcinogenesis; 2004 May; 25(5):801-7. PubMed ID: 14729582 [TBL] [Abstract][Full Text] [Related]
27. Role of exposure/recovery schedule in micronuclei induction by several promutagens in V79-derived cells expressing human CYP2E1 and SULT1A1. Jia H; Zhang C; Glatt H; Liu Y Mutat Res Genet Toxicol Environ Mutagen; 2016 Sep; 808():27-37. PubMed ID: 27637483 [TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Surh YJ; Liem A; Miller EC; Miller JA Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526 [TBL] [Abstract][Full Text] [Related]
29. Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice. Li Y; Chen Z; Paonessa JD; Meinl W; Bhattacharya A; Glatt H; Vouros P; Zhang Y Cancer Med; 2018 Nov; 7(11):5604-5610. PubMed ID: 30306738 [TBL] [Abstract][Full Text] [Related]
30. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Glatt H; Meinl W Carcinogenesis; 2004 May; 25(5):779-86. PubMed ID: 14754874 [TBL] [Abstract][Full Text] [Related]
31. Mutagenicity of 5-hydroxymethylfurfural in V79 cells expressing human SULT1A1: identification and mass spectrometric quantification of DNA adducts formed. Monien BH; Engst W; Barknowitz G; Seidel A; Glatt H Chem Res Toxicol; 2012 Jul; 25(7):1484-92. PubMed ID: 22563731 [TBL] [Abstract][Full Text] [Related]
32. Formation of DNA adducts from 1-hydroxymethylpyrene in liver cells in vivo and in vitro. Monnerjahn S; Seidel A; Steinberg P; Oesch F; Hinz M; Stezowsky JJ; Hewer A; Phillips DH; Glatt HR IARC Sci Publ; 1993; (124):189-93. PubMed ID: 8225483 [TBL] [Abstract][Full Text] [Related]
33. Mutagenicity and DNA adduct formation by the urban air pollutant 2-nitrobenzanthrone. Arlt VM; Glatt H; Gamboa da Costa G; Reynisson J; Takamura-Enya T; Phillips DH Toxicol Sci; 2007 Aug; 98(2):445-57. PubMed ID: 17483118 [TBL] [Abstract][Full Text] [Related]
34. Sulfotransferase-mediated mutagenicity of 1-hydroxymethylpyrene and 4H-cyclopenta[def]chrysen-4-ol and its enhancement by chloride anions. Glatt H; Henschler R; Frank H; Seidel A; Yang C; Abu-Shqara E; Harvey RG Carcinogenesis; 1993 Apr; 14(4):599-602. PubMed ID: 8472321 [TBL] [Abstract][Full Text] [Related]
35. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models. Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869 [TBL] [Abstract][Full Text] [Related]
36. Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters. Bakhiya N; Stephani M; Bahn A; Ugele B; Seidel A; Burckhardt G; Glatt H J Am Soc Nephrol; 2006 May; 17(5):1414-21. PubMed ID: 16597690 [TBL] [Abstract][Full Text] [Related]
37. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012 [TBL] [Abstract][Full Text] [Related]
38. Oxidation of alcohols and reduction of aldehydes derived from methyl- and dimethylpyrenes by cDNA-expressed human alcohol dehydrogenases. Kollock R; Frank H; Seidel A; Meinl W; Glatt H Toxicology; 2008 Mar; 245(1-2):65-75. PubMed ID: 18242813 [TBL] [Abstract][Full Text] [Related]
39. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice. Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152 [TBL] [Abstract][Full Text] [Related]
40. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse. Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]